Recovery of Δf508-CFTR function by analogs of hyaluronan disaccharide

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 156-164

  Nowakowska, Ewa ^a   Schulz, Tobias ^a   Molenda, Natalia ^a   Schillers, Hermann ^a   Prehm, Peter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

CFTR; Cystic fibrosis; Hyaluronan; ion transport

Indexed keywords

2 (2 ACETAMIDO 3,5 DIHYDROXYPHENOXY) 5 AMINOBENZOIC ACID; BENZOIC ACID; CHLORIDE; HYALURONAN DISACCHARIDE; HYALURONIC ACID; IODINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; EFFUSION; EPITHELIUM; HUMAN; HUMAN CELL; MEMBRANE BIOLOGY; MEMBRANE PERMEABILITY; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSEPITHELIAL RESISTANCE;

ACETANILIDES; AMINOBENZOIC ACIDS; BIOLOGICAL TRANSPORT, ACTIVE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FEMALE; HUMANS; HYALURONIC ACID; IODIDES; ION TRANSPORT; NASAL MUCOSA;

EID: 84055177086     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23339     Document Type: Article

References (34)

1. Al-Nakkash L, Hwang TC,. 1999. Activation of wild-type and deltaF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms. Pflugers Arch 437: 553-561. (Pubitemid 29110907)
2. Bobadilla JL, Macek M, Jr., Fine JP, Farrell PM,. 2002. Cystic fibrosis: A worldwide analysis of CFTR mutations-Correlation with incidence data and application to screening. Hum Mutat 19: 575-606. (Pubitemid 34556480)
3. Carlile GW, Robert R, Zhang D, Teske KA, Luo Y, Hanrahan JW, Thomas DY,. 2007. Correctors of protein trafficking defects identified by a novel high-throughput screening assay. Chem Biochem 8: 1012-1020. (Pubitemid 47189285)
4. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M,. 1991. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354: 526-528. (Pubitemid 21896832)
5. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ,. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761-764.
6. Drumm ML, Wilkinson DJ, Smit LS, Worrell RT, Strong TV, Frizzell RA, Dawson DC, Collins FS,. 1991. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science 254: 1797-1799. (Pubitemid 21917530)
7. Du K, Sharma M, Lukacs GL,. 2005. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12: 17-25. (Pubitemid 40082912)
8. Gentzsch M, Chang XB, Cui L, Wu Y, Ozols VV, Choudhury A, Pagano RE, Riordan JR,. 2004. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 15: 2684-2696. (Pubitemid 38691858)
9. Guggino WB,. 1999. Cystic fibrosis and the salt controversy. Cell 96: 607-610. (Pubitemid 29122802)
10. Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ,. 1996. Delta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 270: C1544-C1555.
11. Hwang TC, Wang F, Yang IC, Reenstra WW,. 1997. Genistein potentiates wild-type and delta F508-CFTR channel activity. Am J Physiol 273: C988-C998. (Pubitemid 27422179)
12. Jojovic M, Delpech B, Prehm P, Schumacher U,. 2002. Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice. Cancer Lett 188: 181-189. (Pubitemid 35292343)
13. Kim Chiaw P, Wellhauser L, Huan LJ, Ramjeesingh M, Bear C,. 2010. A chemical corrector modifies the channel function of F508del-CFTR. Mol Pharmacol 78: 411-418.
14. Kopito RR,. 1999. Biosynthesis and degradation of CFTR. Physiol Rev 79: S167-S173. (Pubitemid 29058913)
15. Kukavica-Ibrulj I, Levesque RC,. 2008. Animal models of chronic lung infection with Pseudomonas aeruginosa: Useful tools for cystic fibrosis studies. Lab Anim 42: 389-412.
16. Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC,. 1993. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol 8: 522-529.
17. - channels expressed in Chinese hamster ovary cells. J Physiol 512: 751-764. (Pubitemid 28505306)
18. Lesimple P, Liao J, Robert R, Gruenert DC, Hanrahan JW,. 2010. Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. J Physiol 588: 1195-1209.
19. Loo TW, Bartlett MC, Clarke DM,. 2008. Correctors promote folding of CFTR in the endoplasmic reticulum. Biochem J 413: 29-36. (Pubitemid 351946859)
20. Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR, Grinstein S,. 1994. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J 13: 6076-6086.
21. Moran O,. 2010. Model of the cAMP activation of chloride transport by CFTR channel and the mechanism of potentiators. J Theor Biol 262: 73-79.
22. Nakayama GR, Caton MC, Nova MP, Parandoosh Z,. 1997. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204: 205-208. (Pubitemid 27262014)
23. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS,. 2005. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115: 2564-2571. (Pubitemid 41266219)
24. Pilewski JM, Frizzell RA,. 1999. Role of CFTR in airway disease. Physiol Rev 79: S215-S255. (Pubitemid 29058916)
25. Rubenstein RC, Egan ME, Zeitlin PL,. 1997. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J Clin Invest 100: 2457-2465. (Pubitemid 27514885)
26. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR,. 1996. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271: 635-638. (Pubitemid 26034907)
27. Schuler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, Hug M, Leal T, Lebacq J, Lebecque P, Lenoir G, Stanke F, Wallemacq P, Tummler B, Knowles MR,. 2004. Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros 3 (Suppl 2): 151-155. (Pubitemid 40045589)
28. Schulz T, Schumacher U, Prehm P,. 2007. Hyaluronan export by the ABC-transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem 282: 20999-21004. (Pubitemid 47099934)
29. Schulz T, Schumacher U, Prante C, Sextro W, Prehm P,. 2010. The cystic fibrosis transmembrane conductance regulator (CFTR) can export hyaluronan. Pathobiology 77: 200-209.
30. Sheppard DN, Welsh MJ,. 1999. Structure and function of the CFTR chloride channel. Physiol Rev 79: S23-S45. (Pubitemid 29058908)
31. Wang Y, Loo TW, Bartlett MC, Clarke DM,. 2007. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J Biol Chem 282: 33247-33251. (Pubitemid 350159496)
32. Yang H, Shelat AA, Guy RK, Gopinath VS, Ma T, Du K, Lukacs GL, Taddei A, Folli C, Pedemonte N, Galietta LJ, Verkman AS,. 2003. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating. J Biol Chem 278: 35079-35085. (Pubitemid 37102270)
33. Ye L, Knapp JM, Sangwung P, Fettinger JC, Verkman AS, Kurth MJ,. 2010. Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles. J Med Chem 53: 3772-3781.
34. Yoo CL, Yu GJ, Yang B, Robins LI, Verkman AS, Kurth MJ,. 2008. 4′-Methyl-4,5′-bithiazole-based correctors of defective DeltaF508-CFTR cellular processing. Bioorg Med Chem Lett 18: 2610-2614. (Pubitemid 351503887)